Authors: HOCHHAUS G WAGNER M MOLLMANN HW TROMM A MOLLMANN AC HOMRIGHAUSEN S BARTH J KRIEG M

Citation: G. Hochhaus et al., CORTISOL SUPPRESSION AFTER ORAL DELIVERY OF BUDESONIDE IN PH-MODIFIEDRELEASE CAPSULES, Gastroenterology, 114(4), 1998, pp. 4082-4082

Authors: HOMRIGHAUSEN S WAGNER M MOLLMANN HW MOLLMANN AC BARTH J KRIEG PM TROMM A HOCHHAUS G

Citation: S. Homrighausen et al., INFLUENCE OF FOOD UPTAKE ON THE PHARMACOKINETICS AND SYSTEMIC EFFECTSAFTER SINGLE APPLICATION OF BUDESONIDE PH-MODIFIED RELEASE CAPSULES, Gastroenterology, 114(4), 1998, pp. 4090-4090

Authors: MOLLMANN HW WAGNER M TROMM A MOLLMANN AC HOMRIGHAUSEN S BARTH J KRIEG M HOCHHAUS G

Citation: Hw. Mollmann et al., RELEASE CHARACTERISTICS OF BUDESONIDE FROM PH-MODIFIED RELEASE CAPSULES AND CONTROLLED ILEAL RELEASE CAPSULES, Gastroenterology, 114(4), 1998, pp. 4263-4263

Authors: WAGNER M MOLLMANN HW TROMM A FROEHLICH P MOLLMANN AC HOMRIGHAUSEN S BARTH J KRIEG M HOCHHAUS G

Citation: M. Wagner et al., SYSTEMIC AVAILABILITY AND PHARMACODYNAMIC EFFECTS AFTER MULTIPLE RECTAL ADMINISTRATION OF BUDESONIDE FOAM IN HEALTHY-VOLUNTEERS, Gastroenterology, 114(4), 1998, pp. 4549-4549

Authors: MOLLMAN H HOCHHAUS G ROHATAGI S BARTH J DERENDORF H KRIEG M WEISSER H MOLLMANN AC

Citation: H. Mollman et al., PHARMACOKINETICS AND PHARMACODYNAMICS OF CLOPREDNOL, International journal of clinical pharmacology and therapeutics, 34(1), 1996, pp. 1-5